- Home
- Publications
- Publication Search
- Publication Details
Title
Denosumab
Authors
Keywords
-
Journal
DRUGS
Volume 71, Issue 8, Pages 1059-1069
Publisher
Springer Nature
Online
2011-06-15
DOI
10.2165/11207370-000000000-00000
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Randomized, Double-Blind Study of Denosumab Versus Zoledronic Acid in the Treatment of Bone Metastases in Patients With Advanced Cancer (Excluding Breast and Prostate Cancer) or Multiple Myeloma
- (2011) David H. Henry et al. JOURNAL OF CLINICAL ONCOLOGY
- Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study
- (2011) Karim Fizazi et al. LANCET
- Denosumab
- (2010) Victoria J. Muir et al. BIODRUGS
- Clinical development of anti-RANKL therapies for treatment and prevention of bone metastasis
- (2010) Allan Lipton et al. BONE
- Denosumab
- (2010) Marit D. Moen et al. DRUGS & AGING
- Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study
- (2010) Alison T. Stopeck et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized Phase II Trial of Denosumab in Patients With Bone Metastases From Prostate Cancer, Breast Cancer, or Other Neoplasms After Intravenous Bisphosphonates
- (2009) Karim Fizazi et al. JOURNAL OF CLINICAL ONCOLOGY
- Risks and benefits of bisphosphonates
- (2008) R E Coleman BRITISH JOURNAL OF CANCER
- Phase 1 trial of denosumab safety, pharmacokinetics, and pharmacodynamics in Japanese women with breast cancer-related bone metastases
- (2008) Kan Yonemori et al. CANCER SCIENCE
- Bone markers and their prognostic value in metastatic bone disease: Clinical evidence and future directions
- (2008) Robert Coleman et al. CANCER TREATMENT REVIEWS
- Advancing Treatment for Metastatic Bone Cancer: Consensus Recommendations from the Second Cambridge Conference
- (2008) R. E. Coleman et al. CLINICAL CANCER RESEARCH
- Extended Efficacy and Safety of Denosumab in Breast Cancer Patients with Bone Metastases Not Receiving Prior Bisphosphonate Therapy
- (2008) A. Lipton et al. CLINICAL CANCER RESEARCH
- Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease
- (2008) Ann E. Kearns et al. ENDOCRINE REVIEWS
- Denosumab, a Fully Human Monoclonal Antibody to RANKL, Inhibits Bone Resorption and Increases BMD in Knock-In Mice That Express Chimeric (Murine/Human) RANKL*
- (2008) Paul J Kostenuik et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Comparison of Effects of the Bisphosphonate Alendronate Versus the RANKL Inhibitor Denosumab on Murine Fracture Healing
- (2008) Louis C Gerstenfeld et al. JOURNAL OF BONE AND MINERAL RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started